Early Life
Clemens Fischer was born on May 28, 1975, in Weilheim, Germany. As a child, he spent time with injured people and dead people because his mother was an operating room nurse.
Rise to Success
Fischer began his career in the pharmaceutical industry. After working at Novartis, he founded Futrue, an international healthcare group. Futrue has over 20 companies specializing in areas such as bacteria, pain therapies, and medical cannabis. He also founded Synformulas, which sells the over-the-counter probiotic Kijimea, and PharmaSGP. In 2007, he was awarded the "CEO of the Future" award by McKinsey and Manager Magazin. Fischer is known for developing the cannabinoid-based pain medication, VER-01, through Vertanical.
Key Business Strategies
Fischer focuses on building and selling companies after successfully positioning them in the market. He is known for aggressive marketing and is also focused on scientific-based therapies, with VER-01 in the final stages of clinical trials. He is also the Chairman-Supervisory Board of PharmaSGP Holding SE.
Philanthropy
While specific figures are unavailable, Fischer has been known to donate to various political parties, including the CDU, SPD, and CSU in Germany, with hundreds of thousands of euros.